Generic Sweden AB (publ) OMXSTO:GENI:
Q3 NET SALES INCREASED BY 5.3% TO 45.3 MSEK
JUL-SEP EBIT INCREASED BY 15.2% TO 10.2 MSEK
Generic Sweden Q3 Net Sales SEK 45.3 Mln
Earlier from Generic Sweden Ab
- Generic Sweden AB: Quarterly Trading Report 2025 Q3
- GENI: Strong EBIT growth and improved margins in Q2 2025, led by SaaS and secure communication services
- GENI: SaaS-driven margin growth and strong DOCS adoption boost results amid CEO transition
- GENI: Record revenue and profit growth in 2024, fueled by SaaS and public sector wins